Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila A Doggrell

Showing results (91-100 of 220) with videos related to

Pageof 22
Sort By:
Expert Opinion on Pharmacotherapy|June 26, 2012
The ezetimibe controversy - can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together?Sheila A Doggrell
Expert Opinion on Biological Therapy|May 21, 2025
With guselkumab, does the dual mechanisms to inhibit IL-23, help in ulcerative colitis?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|June 27, 2002
Metformin & lifestyle intervention prevent Type 2 diabetes: lifestyle intervention has the greater effectSheila A Doggrell
Expert Opinion on Investigational Drugs|May 9, 2002
Immunomodulation with DiNAC-- a new approach to the treatment of atherosclerosis?Sheila A Doggrell
Drugs of Today (Barcelona, Spain : 1998)|May 17, 2003
Brain natriuretic peptide: Disease marker or more in cardiovascular medicine?Sheila A. Doggrell
Expert Opinion on Pharmacotherapy|May 4, 2011
Sitagliptin or exenatide once weekly for type 2 diabetes: comparison of the clinical trialsSheila A Doggrell
Evidence-Based Complementary and Alternative Medicine : Ecam|April 23, 2009
Lyprinol-is it a useful anti-inflammatory agent?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|September 23, 2008
Is rimonabant efficacious and safe in the treatment of obesity?Sheila A Doggrell
Expert Opinion on Biological Therapy|September 24, 2021
Do we need bamlanivimab? Is etesevimab a key to treating Covid-19?Sheila A Doggrell
Expert Review of Anticancer Therapy|September 19, 2009
Clinical efficacy and safety of zoledronic acid in prostate and breast cancerSheila A Doggrell
Pageof 22

Showing results (91-100 of 220) with videos related to

Sort By:
Pageof 22
Expert Opinion on Pharmacotherapy|June 26, 2012
The ezetimibe controversy - can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together?Sheila A Doggrell
Expert Opinion on Biological Therapy|May 21, 2025
With guselkumab, does the dual mechanisms to inhibit IL-23, help in ulcerative colitis?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|June 27, 2002
Metformin & lifestyle intervention prevent Type 2 diabetes: lifestyle intervention has the greater effectSheila A Doggrell
Expert Opinion on Investigational Drugs|May 9, 2002
Immunomodulation with DiNAC-- a new approach to the treatment of atherosclerosis?Sheila A Doggrell
Drugs of Today (Barcelona, Spain : 1998)|May 17, 2003
Brain natriuretic peptide: Disease marker or more in cardiovascular medicine?Sheila A. Doggrell
Expert Opinion on Pharmacotherapy|May 4, 2011
Sitagliptin or exenatide once weekly for type 2 diabetes: comparison of the clinical trialsSheila A Doggrell
Evidence-Based Complementary and Alternative Medicine : Ecam|April 23, 2009
Lyprinol-is it a useful anti-inflammatory agent?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|September 23, 2008
Is rimonabant efficacious and safe in the treatment of obesity?Sheila A Doggrell
Expert Opinion on Biological Therapy|September 24, 2021
Do we need bamlanivimab? Is etesevimab a key to treating Covid-19?Sheila A Doggrell
Expert Review of Anticancer Therapy|September 19, 2009
Clinical efficacy and safety of zoledronic acid in prostate and breast cancerSheila A Doggrell
Pageof 22